StockData
Moleculin Biotech, Inc. logo

Moleculin Biotech, Inc. (MBRX) stock

MBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$6.75−0.08 (-1.17%)

Close on Nov 18, 2026Market cap $131.47MP/E –Yield –

Moleculin Biotech free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Moleculin Biotech's free cash flow for the twelve months ending Dec 31, 2025 was -$22.74M. For fiscal 2025 it was -$22.74M. The highest annual figure on record is -$3.79M in fiscal 2016.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$22.74M–
FY2024Dec 31, 2024-$23.88M–
FY2023Dec 31, 2023-$23.72M–
FY2022Dec 31, 2022-$27.71M–
FY2021Dec 31, 2021-$18.97M–
FY2020Dec 31, 2020-$18.15M–
FY2019Dec 31, 2019-$17.25M–
FY2018Dec 31, 2018-$12.62M–
FY2017Dec 31, 2017-$7.35M–
FY2016Dec 31, 2016-$3.79M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$5.37M–
Q3 FY2025Sep 30, 2025-$7.22M–
Q2 FY2025Jun 30, 2025-$5.58M–
Q1 FY2025Mar 31, 2025-$4.56M–
Q4 FY2024Dec 31, 2024-$5.08M–
Q3 FY2024Sep 30, 2024-$6.11M–
Q2 FY2024Jun 30, 2024-$5.96M–
Q1 FY2024Mar 31, 2024-$6.72M–
Q4 FY2023Dec 31, 2023-$4.98M–
Q3 FY2023Sep 30, 2023-$7.58M–
Q2 FY2023Jun 30, 2023-$5.14M–
Q1 FY2023Mar 31, 2023-$6.02M–
Q4 FY2022Dec 31, 2022-$7.26M–
Q3 FY2022Sep 30, 2022-$7.58M–
Q2 FY2022Jun 30, 2022-$8.06M–
Q1 FY2022Mar 31, 2022-$4.81M–
Q4 FY2021Dec 31, 2021-$4.28M–
Q3 FY2021Sep 30, 2021-$4.29M–
Q2 FY2021Jun 30, 2021-$6.78M–
Q1 FY2021Mar 31, 2021-$3.62M–
Q4 FY2020Dec 31, 2020-$3.14M–
Q3 FY2020Sep 30, 2020-$5.71M–
Q2 FY2020Jun 30, 2020-$4.95M–
Q1 FY2020Mar 31, 2020-$4.34M–
Q4 FY2019Dec 31, 2019-$4.69M–
Q3 FY2019Sep 30, 2019-$3.34M–
Q2 FY2019Jun 30, 2019-$5.37M–
Q1 FY2019Mar 31, 2019-$3.86M–
Q4 FY2018Dec 31, 2018-$3.22M–
Q3 FY2018Sep 30, 2018-$3.11M–
Q2 FY2018Jun 30, 2018-$3.47M–
Q1 FY2018Mar 31, 2018-$2.82M–
Q4 FY2017Dec 31, 2017-$2.41M–
Q3 FY2017Sep 30, 2017-$1.62M–
Q4 FY2016Dec 31, 2016-$1.18M–
Q3 FY2016Sep 30, 2016-$961.00K–

More Moleculin Biotech figures

See a number that looks wrong?